Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

Drug Use and Addiction Research Programs

Drug Use and Addiction Research Programs (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 162 Aufrufe auf der Seite, davon 17 offen; Aufrufe starten meist im September. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: National Institutes of Health (Department of Health and Human Services)

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
17
Aufrufe auf der Seite
162

Aufrufe starten meist im September

Über das Programm

Objectives: To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS.…

Mehr in der Quelle

Offene Aufrufe

FörderaufrufStatusFrist
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)Offen8. Februar 2027
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) (Runde 08.2024 – 02.2027)Offen11. Februar 2027
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)Offen5. März 2027
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) (Runde 08.2024 – 03.2027)Offen6. März 2027
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) (Runde 12.2024 – 08.2027)Offen11. August 2027
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)Offen27. Oktober 2027
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (Runde 08.2026 – 06.2028)Offen16. Juni 2028
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)Offen21. August 2028
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)Offen25. September 2028
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)Offen5. November 2028
Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)Offen16. März 2029
Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)Offen16. Juli 2029
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2Geplant—
NIDA Avenir Program: Fundamental Mechanistic Research in Addiction ScienceGeplant—
Intervention Research to Improve Native American HealthGeplant—
NIDA Core "Center of Transformative Science" Grant ProgramGeplant—
NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous SystemGeplant—

Frühere Aufrufe

FörderaufrufStatusFrist
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)Abgelaufen13. November 2026
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)Abgelaufen27. Oktober 2026
Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)Abgelaufen1. Oktober 2026
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)Abgelaufen30. September 2026
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) (Runde 01.2025 – 09.2026)Abgelaufen7. September 2026
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)Abgelaufen5. September 2026
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (Runde 11.2024 – 08.2026)Abgelaufen13. August 2026
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) (Runde 09.2024 – 07.2026)Abgelaufen29. Juli 2026
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) (Runde 12.2024 – 07.2026)Abgelaufen29. Juli 2026
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (Runde 11.2024 – 07.2026)Abgelaufen6. Juli 2026
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed) (Runde 08.2024 – 03.2026)Abgelaufen19. März 2026
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)Abgelaufen11. März 2026
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)Abgelaufen10. März 2026

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

Drug Use and Addiction Research Programs: Wann starten die Förderaufrufe?
Derzeit offen (17): Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory… (8. Februar 2027), NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) (11. Februar 2027), High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) (5. März 2027), …. Aufrufe starten meist im September.